The Week That Wasn't: Famotidine, Hospital Spread, Mask Markup The Week That Wasn't: Famotidine, Hospital Spread, Mask Markup
Three medical stories that we didn ' t cover, explained.Medscape (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - June 12, 2020 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Could Heartburn Med Pepcid Ease COVID-19 Symptoms?
Famotidine, sold under the brand name Pepcid, appeared to improve symptoms in a group of 10 patients diagnosed with COVID-19, researchers reported online June 4 in the journal Gut. (Source: WebMD Health)
Source: WebMD Health - June 5, 2020 Category: Consumer Health News Source Type: news

Some COVID-19 Outpatients Say Famotidine Eased Symptoms
FRIDAY, June 5, 2020 -- A small number of nonhospitalized patients with COVID-19 who self-medicated with high-dose famotidine reported some relief of their symptoms, according to a case series published online June 4 in Gut. Tobias Janowitz, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 5, 2020 Category: Pharmaceuticals Source Type: news

Could Heartburn Med Pepcid Ease COVID-19 Symptoms?
THURSDAY, June 4, 2020 -- An over-the-counter heartburn remedy is showing some potential as a symptom reliever for COVID-19, a small study finds. Famotidine, sold under the brand name Pepcid, appeared to improve symptoms in a group of 10 patients... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 4, 2020 Category: General Medicine Source Type: news

Applying symptom tracking to COVID-19 outpatient care using famotidine
(Cold Spring Harbor Laboratory) Researchers are developing methods to test COVID-19 treatments on non-hospitalized patients. The Northwell-CSHL team of clinicians/researchers used famotidine as a proof-of-concept that outpatient symptom tracking may accelerate prioritization of effective drug regimens to be pursued more rigorously in clinical trials. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 4, 2020 Category: Infectious Diseases Source Type: news

Study shows Covid-19 patients who took heartburn drug were less likely to die, but researchers caution more research is needed
Patients who took a common heartburn medicine while hospitalized for Covid-19 were more than twice as likely to survive the infection, according to a paper posted Friday on a pre-publication website. But it's unclear whether the patients fared better because of the famotidine or if it was a coincidence. (Source: CNN.com - Health)
Source: CNN.com - Health - May 10, 2020 Category: Consumer Health News Source Type: news

Researchers studying a common heartburn drug as treatment for Covid-19
Hospitals in New York are giving Covid-19 patients the heartburn medicine famotidine to see if it helps fight the virus, according to the doctor who initiated the trial. (Source: CNN.com - Health)
Source: CNN.com - Health - April 27, 2020 Category: Consumer Health News Source Type: news

FDA Calls For Heartburn Drug Zantac To Be Pulled From Market Immediately
(CNN) — The US Food and Drug Administration is requesting that manufacturers pull all prescription and over-the-counter ranitidine drugs, known by the brand name Zantac, from the market immediately, the agency announced on Wednesday. The FDA noted that an ongoing investigation has determined that levels of a contaminant in the heartburn medications increase over time and when stored at higher-than-normal temperatures, poses a risk to public health. The contaminant, N-nitrosodimethylamine or NDMA, is a probable human carcinogen and the FDA has been investigating levels of it in ranitidine since the summer of 2019. ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 1, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated CBSN Boston CNN Zantac Source Type: news

Medicine Supply Notifications - Clonidine and H2-antagonists (cimetidine, famotidine and nizatidine)
The Department of Health and Social Care (DHSC) has issued the following Medicine Supply Notifications: (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - December 23, 2019 Category: Drugs & Pharmacology Source Type: news

PPI, H2RA Equally Good at Preventing Bleeding Recurrence in H. Pylori-Negative Ulcers PPI, H2RA Equally Good at Preventing Bleeding Recurrence in H. Pylori-Negative Ulcers
Lansoprazole and famotidine have comparable effects in preventing recurrent idiopathic gastroduodenal ulcer bleeding, a two-year randomized clinical trial shows.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 12, 2019 Category: Consumer Health News Tags: Medscape Today News Source Type: news